doi: 10.1200/JCO.18.01360.
Epub 2019 Feb 11.
Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Affiliations
- PMID: 30742565
- DOI: 10.1200/JCO.18.01360
Item in Clipboard
Ovarian Suppression in Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
J Clin Oncol.
.
No abstract available
Comment in
-
Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors.J Clin Oncol. 2019 Jul 20;37(21):1838-1840. doi: 10.1200/JCO.19.00559. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173554 Free PMC article. No abstract available.
-
Reply to F. Conforti et al.J Clin Oncol. 2019 Jul 20;37(21):1840-1841. doi: 10.1200/JCO.19.01133. Epub 2019 Jun 7. J Clin Oncol. 2019. PMID: 31173556 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
